US · 1 entry · 1 publication
Immix Biopharma, Inc.
No entry states a stance.
Free during launch: log in or sign up with your email to see it.
Sign up freeSubstack · BioEquity Watch
Rating: BULLISH | Target Price: $21.20 | Current Price: $8.95 | Implied Change: +155.68%
Since publication IMMX −5.4% α −9.0 pp vs S&P 500 · USD
Prices as of the Oct 27, 2026 close. Past performance does not guarantee future results. Price-only, excluding dividends, in local currency. Data may be delayed or inaccurate. Not investment advice. How it is calculated.